scholarly journals Medical Officers of Health, Public Health and Preventive Medicine Specialists, and Primary Care Physicians: How Do They Fit?

2013 ◽  
Vol 104 (2) ◽  
pp. e111-e112 ◽  
Author(s):  
Stephen Corber
Antibiotics ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 629
Author(s):  
António Teixeira Rodrigues ◽  
João C. F. Nunes ◽  
Marta Estrela ◽  
Adolfo Figueiras ◽  
Fátima Roque ◽  
...  

Background: Antibiotic resistance is a worldwide public health problem, leading to longer hospital stays, raising medical costs and mortality levels. As physicians’ attitudes are key factors to antibiotic prescribing, this study sought to explore their differences between primary care and hospital settings. Methods: A survey was conducted between September 2011 and February 2012 in the center region of Portugal in the form of a questionnaire to compare hospital (n = 154) and primary care (n = 421) physicians’ attitudes and knowledge regarding antibiotic prescribing. Results: More than 70% of the attitudes were statistically different (p < 0.05) between hospital physicians (HPs) and primary care physicians (PCPs). When compared to PCPs, HPs showed higher agreement with antibiotic resistances being a public health problem and ascribed more importance to microbiological tests and to the influence of prescription on the development of resistances. On the other hand, PCPs tended to agree more regarding the negative impact of self-medication with antibiotics dispensed without medical prescription and the need for rapid diagnostic tests. Seven out of nine sources of knowledge’s usefulness were statistically different between both settings, with HPs considering most of the knowledge sources to be more useful than PCPs. Conclusions: Besides the efforts made to improve both antibiotic prescribing and use, there are differences in the opinions between physicians working in different settings that might impact the quality of antibiotic prescribing. In the future, these differences must be considered to develop more appropriate interventions.


1998 ◽  
Vol 104 (2) ◽  
pp. 152-158 ◽  
Author(s):  
Paul G Ramsey ◽  
J.Randall Curtis ◽  
Douglas S Paauw ◽  
Jan D Carline ◽  
Marjorie D Wenrich

2011 ◽  
Vol 15 (4) ◽  
pp. 185-191 ◽  
Author(s):  
Lyn C. Guenther ◽  
Charles W. Lynde

Background: Herpes zoster (HZ) and postherpetic neuralgia (PHN) have a significant impact on quality of life. PHN is often chronic and difficult to treat. Dermatologists have always been involved in making the diagnosis of these conditions and, most recently, teaching the need for early antiviral therapy. Objective: With the introduction of a new vaccine, HZ and its difficult-to-treat complication PHN can be prevented or minimized. Preventive medicine is important and has been supported by dermatologists with sun safety programs. Patients receiving biologics are at increased risk of developing zoster. Conclusion: Dermatologists should embrace zoster vaccination and recommend routine vaccination of immunocompetent individuals > age 60 years, as well as patients of any age who are starting immunosuppressants, including biologics. Given that individuals over age 50 years are at risk for PHN and studies have shown that the vaccine's immunogenicity and safety are maintained in individuals age 50 to 59 years, vaccination in this age group may be considered. Some dermatologists may consider vaccinating their own patients, but most will likely recommend that vaccination be performed by their patients' primary care physicians.


Author(s):  
M. D. Abu Bashar ◽  
Nazia Begam

Diabetes is a major worldwide epidemic and a public health challenge of 21<sup>st</sup> century with &gt;415 million individuals living with the disease and this number is expected to grow to staggering 642 million by 2040. Of patients with this disease, 90% to 95% have type 2 DM. Factors contributing to this increase mainly of type 2 diabetes include an aging population, improved survival rates, and the increasing prevalence of overweight or obesity.


2021 ◽  
pp. 120347542110533
Author(s):  
Edgar Akuffo-Addo ◽  
Mathew N. Nicholas ◽  
Marissa Joseph

Coronavirus disease (COVID-19) skin manifestations have been increasingly reported in medical literature. Recent discussions have identified a lack of images of skin of color (SOC) patients with COVID-19 related skin findings despite people with skin of color being disproportionately affected with the disease. There have been calls to prioritize the identification of COVID-19 skin manifestations in patients with SOC and disseminate these findings. The objective of this article is to review the existing literature on COVID-19 skin manifestations and, where possible, discuss how they may present differently in patients with SOC. Further research is needed to allow primary care physicians and dermatologists to be aware of and easily identify patients with cutaneous findings that may be secondary to COVID-19. Patients presenting with idiopathic dermatologic manifestations should be considered for COVID-19 testing and follow public health guidelines for self-isolation.


2016 ◽  
Vol 7 (1) ◽  
pp. 5 ◽  
Author(s):  
David Snipelisky ◽  
Kimberly Carter ◽  
Karna Sundsted ◽  
MCaroline Burton

Sign in / Sign up

Export Citation Format

Share Document